Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Rakon Limited Director's Dealing 2025

Oct 28, 2025

66260_rns_2025-10-29_aae0224f-557c-422c-9fb9-10d3a700deaf.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [82 x 23] intentionally omitted <==

Initial Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(1) and 298(1), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer: Rakon Limited
Date this disclosure made: 28-Oct-25
Date on which issuer listed or appointment made: 28-Oct-25
Director or senior manager giving disclosure
Full name: Christopher Grant Swasbrook
Name of listed issuer: Rakon Limited
Name of related bodycorporate(if applicable):
Position held in listed issuer: Independent Director
Summary of relevant interest (excluding specified derivatives)
Class of quoted financial product: Ordinary Shares
Number held in class: 1,350,000
Nature of relevant interest: Power to Influence as Portfolio Manager & Director
Current registered holder: Public Trust as Custodian for Elevation Capital Global Shares Fund
Summary of specified derivatives relevant interest (if applicable)
Type of derivative:
Class of underlyingfinancialproducts:
Details of derivative
The notional value of the derivative (if any) or the notional amount of underlying
products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturitydate of the derivative (if any):
Expirydate of the derivative (if any):
Theprice specified in the terms of the derivative(if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlyingfinancialproducts:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer: Chris Swasbrook
Date of signature: 28-Oct-25
or
Signature ofperson authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
Notes

Use this form to disclose the relevant interests that a director or senior manager of a listed issuer has in quoted financial products of the listed issuer or a related body corporate or a specified derivative. The disclosure must be made within 5 trading days of—

(a) the listing of the public issuer; or

(b) the person’s appointment as a director or senior manager.